"$2b in revenue before oncology"

I'd anticipate as soon as Defencath is approved that they discuss with FDA the pathway for Oncology and should have a trial protocol lined up by now, at least i'd hope. That would be a 2-3 year timeline to completion. You think.....little ole CRMD....is going to grow $2b in sales by then? I'm not so sure i trust them to even grow to $1b in revenue on their own.